Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Draflazine: a potential cardioprotectant with a novel mechanism of action

Oct. 17, 1997

No Comments

Alpha1-antichymotrypsin analogues described in patent literature

Oct. 17, 1997

No Comments

Do calcium channel blockers increase risk of cancer?

Oct. 16, 1997

No Comments

Takeda's Blopress approved in EC

Oct. 16, 1997

No Comments

Novel squalene synthase inhibitor reported by Pfizer

Oct. 15, 1997

No Comments

Lenercept evaluated in phase II for sepsis/septic shock; development for RA halted

Oct. 15, 1997

No Comments

New agent for restenosis reported by Taiho

Oct. 15, 1997

No Comments

PRIME II: another heart failure drug associated with increased mortality

Oct. 15, 1997

No Comments

Cardiovascular/Renal Drugs Advisory Committee meets this month

Oct. 14, 1997

No Comments

DCLHb evaluated in critically ill patients

Oct. 13, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cardiovascular
RSS

Draflazine: a potential cardioprotectant with a novel mechanism of action

Alpha1-antichymotrypsin analogues described in patent literature

Do calcium channel blockers increase risk of cancer?

Takeda's Blopress approved in EC

Novel squalene synthase inhibitor reported by Pfizer

Lenercept evaluated in phase II for sepsis/septic shock; development for RA halted

New agent for restenosis reported by Taiho

PRIME II: another heart failure drug associated with increased mortality

Cardiovascular/Renal Drugs Advisory Committee meets this month

DCLHb evaluated in critically ill patients

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Cardiovascular RSS

Cardiovascular
RSS